The decision [to rehire] came after a devastating period in China for the British pharmaceutical giant. Two years ago, investigators in China detained senior executives and sales managers. Eventually, five senior executives were convicted and the company was fined nearly $500 million for bribing doctors, hospitals and others to bolster sales in China.

Citeste intregul articolul aici.